From their announcement today:
SCU believes the sector is complementary to its existing operations and the Company can leverage its extensive experience, technologies and operational synergies from its existing Traditional Chinese Medicine (TCM) plant extract business.
"leverage"?
that will improve on:
Growers CLONE from clippings of a chosen parent strain.
FLOWERING MATURE female plant give us the cannabinoid-rich buds, that contain high concentrations of trichomes (mushroom-shaped glands), that secrete aromatic oils called terpenes as well as therapeutic cannabinoids like thc and cbd.
ROSIN extraction, heat and pressure, nearly instantaneously squeezes resinous sap from the cannabis flowers giving a translucent sappy extract rivaling or exceeding the flavor, potency, and yield of more complicated solvent-based methods.
Info from www.leafly.com
Ann: SCU to pursue opportunities in Medicinal Cannabis sector, page-114
-
- There are more pages in this discussion • 228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BP8 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.189M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.396K | 798.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 26812499 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 1467600 | 2 |
View Market Depth
| Last trade - 15.41pm 17/07/2024 (20 minute delay) ? |
| BP8 (ASX) Chart |